Cargando…

Riboflavin Has Neuroprotective Potential: Focus on Parkinson’s Disease and Migraine

With the huge negative impact of neurological disorders on patient’s life and society resources, the discovery of neuroprotective agents is critical and cost-effective. Neuroprotective agents can prevent and/or modify the course of neurological disorders. Despite being underestimated, riboflavin off...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marashly, Eyad T., Bohlega, Saeed A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5517396/ https://www.ncbi.nlm.nih.gov/pubmed/28775706 http://dx.doi.org/10.3389/fneur.2017.00333

Ejemplares similares

Riboflavin, a Potent Neuroprotective Vitamin: Focus on Flavivirus and Alphavirus Proteases
por: Eberle, Raphael J., et al.
Publicado: (2022)

Riboflavin prophylaxis in pediatric and adolescent migraine
por: Condò, Maria, et al.
Publicado: (2009)

The Promise of Neuroprotective Agents in Parkinson’s Disease
por: Seidl, Stacey E., et al.
Publicado: (2011)

Erratum: The promise of neuroprotective agents in Parkinson's disease
por: Seidl, Stacey E., et al.
Publicado: (2013)

Experimental and Clinical Evidence of the Effectiveness of Riboflavin on Migraines
por: Yamanaka, Gaku, et al.
Publicado: (2021)

Lactoferrin: neuroprotection against Parkinson's disease and secondary molecule for potential treatment
por: Eker, Furkan, et al.
Publicado: (2023)

Medical Management of Parkinson’s Disease: Focus on Neuroprotection
por: Boll, Marie-Catherine, et al.
Publicado: (2011)

Exercise-Induced Neuroprotection of the Nigrostriatal Dopamine System in Parkinson's Disease
por: Hou, Lijuan, et al.
Publicado: (2017)

Gene Therapy: A Promising Approach for Neuroprotection in Parkinson’s Disease?
por: Valdés, Pamela, et al.
Publicado: (2016)

The Emerging Role of Energy Metabolism and Neuroprotective Strategies in Parkinson's Disease
por: Błaszczyk, Janusz W.
Publicado: (2018)

Parkinson’s Disease: Can Targeting Inflammation Be an Effective Neuroprotective Strategy?
por: Gundersen, Vidar
Publicado: (2021)

Glutamic Acid Transporters: Targets for Neuroprotective Therapies in Parkinson’s Disease
por: Li, Xiang, et al.
Publicado: (2021)

Commentary: Gene Therapy: A Promising Approach for Neuroprotection in Parkinson's Disease?
por: Segura-Aguilar, Juan
Publicado: (2017)

c-Abl Inhibitors Enable Insights into the Pathophysiology and Neuroprotection in Parkinson’s Disease
por: Lindholm, Dan, et al.
Publicado: (2016)

Neuroprotective Potential and Underlying Pharmacological Mechanism of Carvacrol for Alzheimer’s and Parkinson’s Diseases
por: Javed, Hayate, et al.
Publicado: (2023)

Tremor in Parkinson’s Disease: From Pathophysiology to Advanced Therapies
por: Abusrair, Ali H., et al.
Publicado: (2022)

Translation Imaging in Parkinson’s Disease: Focus on Neuroinflammation
por: Belloli, Sara, et al.
Publicado: (2020)

Catalpol Exerts a Neuroprotective Effect in the MPTP Mouse Model of Parkinson’s Disease
por: Wang, Li-Yuan, et al.
Publicado: (2019)

Orexin-A Exerts Neuroprotective Effects via OX1R in Parkinson’s Disease
por: Liu, Mei-Fang, et al.
Publicado: (2018)

Fisetin Regulates Gut Microbiota and Exerts Neuroprotective Effect on Mouse Model of Parkinson’s Disease
por: Chen, Tian-Jiao, et al.
Publicado: (2020)

The neuroprotective effects of glucagon-like peptide 1 in Alzheimer’s and Parkinson’s disease: An in-depth review
por: Reich, Niklas, et al.
Publicado: (2022)

Microvascular Changes in Parkinson’s Disease- Focus on the Neurovascular Unit
por: Paul, Gesine, et al.
Publicado: (2022)

Triglyceride Form of Docosahexaenoic Acid Mediates Neuroprotection in Experimental Parkinsonism
por: Gómez-Soler, Maricel, et al.
Publicado: (2018)

Gait Stability Has Phase-Dependent Dual-Task Costs in Parkinson’s Disease
por: Fino, Peter C., et al.
Publicado: (2018)

Regulation and targeting of enzymes mediating Parkinson's disease pathogenesis: focus on Parkinson's disease kinases, GTPases, and ATPases
por: Taymans, Jean-Marc, et al.
Publicado: (2014)

Retinoic acid-loaded polymeric nanoparticles induce neuroprotection in a mouse model for Parkinson's disease
por: Esteves, Marta, et al.
Publicado: (2015)

Neuroprotective and therapeutic effects of calcitriol in rotenone-induced Parkinson’s disease rat model
por: Magdy, Alshimaa, et al.
Publicado: (2022)

Neuroprotective Effect of Physical Activity in Ischemic Stroke: Focus on the Neurovascular Unit
por: Zhang, Hui, et al.
Publicado: (2022)

The Neuroprotective Disease-Modifying Potential of Psychotropics in Parkinson's Disease
por: Lauterbach, Edward C., et al.
Publicado: (2012)

Mitochondrial Quality Control in Neurodegenerative Diseases: Focus on Parkinson's Disease and Huntington's Disease
por: Franco-Iborra, Sandra, et al.
Publicado: (2018)

Neuroprotective potential of Beta vulgaris L. in Parkinson's disease
por: Nade, Vandana S., et al.
Publicado: (2015)

From the bench to the bedside: Emerging science in Parkinson’s disease, cholesterol metabolism, and neuroprotection
por: Hauptman, Jason S.
Publicado: (2010)

Long-Term Continuous Cervical Spinal Cord Stimulation Exerts Neuroprotective Effects in Experimental Parkinson’s Disease
por: Kuwahara, Ken, et al.
Publicado: (2020)

Neuroprotection by the Immunomodulatory Drug Pomalidomide in the Drosophila LRRK2(WD40) Genetic Model of Parkinson’s Disease
por: Casu, Maria Antonietta, et al.
Publicado: (2020)

Riboflavin Inhibits Histamine-Dependent Itch by Modulating Transient Receptor Potential Vanilloid 1 (TRPV1)
por: Lee, Kihwan, et al.
Publicado: (2021)

Methanol-induced parkinsonism and cerebral vasculopathy due to perfume inhalation
por: B Mohammed, Walaa, et al.
Publicado: (2022)

Neuroprotection Against Parkinson’s Disease Through the Activation of Akt/GSK3β Signaling Pathway by Tovophyllin A
por: Huang, Yanjun, et al.
Publicado: (2020)

Neuroprotective and Neurorestorative Effects of Holothuria scabra Extract in the MPTP/MPP(+)-Induced Mouse and Cellular Models of Parkinson’s Disease
por: Noonong, Kunwadee, et al.
Publicado: (2020)

Voltage-Gated Ca(2+) Channels in Dopaminergic Substantia Nigra Neurons: Therapeutic Targets for Neuroprotection in Parkinson's Disease?
por: Ortner, Nadine J.
Publicado: (2021)

Mitochondrial Preconditioning: A Potential Neuroprotective Strategy
por: Correia, Sónia C., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_8rb52k6ka5eesc43m7hegloiq2